The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $100.87

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $100.87

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Core Laboratories NV closed at (U.S.)$100.87.

Over the last five days, shares have gained 2.51%, but are down 7.24% for the last year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $100.87
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-7.24%
  • Volume0
  • Average volume (10-day)1,133,408
  • Average volume (1-month)832,184
  • Average volume (3-month)713,696
  • 52-week range(U.S.) $84.50 to (U.S.) $134.87
  • Beta1.40
  • Trailing P/E37.73×
  • P/E 1 year forward49.95×
  • Forward PEG2.50×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield2.18%
  • Trailing EPS(U.S.) $2.67
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.41%

Based on its net profit margin of 14.41%, Core Laboratories NV is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:EnergyIndustry:Oil Related Services & Equipment

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue183197204214
Total other revenue--------
Total revenue183197204214
Gross profit58686969
Total cost of revenue125129135144
Total operating expense159150156171
Selling / general / administrative12121313
Research & development--------
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)16007
Other operating expenses, total-1010
Operating income24474843
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax20434540
Income after tax16343531
Income tax, total510109
Net income15333531
Total adjustments to net income--------
Net income before extra. items15333531
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items15333531
Inc. avail. to common incl. extra. items15333531
Diluted net income15333531
Dilution adjustment--------
Diluted weighted average shares43434343
Diluted EPS excluding extraordinary itemsvalue per share0.360.780.810.72
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.650.780.800.85